CYTK CapEx to Revenue

Cytokinetics Inc · CapEx to Revenue

CYTK logo

CYTK CapEx to Revenue

Current (TTM)35.60%
CYTK CapEx/Revenue (0.00% → 35.60%)
High-resolution chart · PNG

CYTK capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
28.1773%
21.1432%
18.8048%
11.9835%
69.3929%
19.7965%
9.7477%
2.8221%
21.5215%
1.4999%
1.9611%
2.3519%
1.7685%
1.6537%
11.075%
19.1308%
0.6745%
5.2979%
18.8152%
171.7301%
16.4385%
10.4151%
28.8456%
57.6518%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.